MONITORING THE COMPARATIVE SAFETY OF SGLT2I VS GLP-1 RA IN OLDER ADULTS WITH TYPE 2 DIABETES BY FRAILTY STATUS

被引：0
|
作者：
Kutz, Alexander [1 ]
Patorno, Elisabetta [2 ,3 ]
Gopalakrishnan, Chandrasekar [2 ,3 ]
Kim, Dae [4 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Boston, MA USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Hebrew SeniorLife, Boston, MA USA
来源：
INNOVATION IN AGING | 2021年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：208 / 208
页数：1
相关论文
共 50 条
  • [41] Effects of GLP-1RA and SGLT2i, Alone or in Combination, on Mouse Models of Type 2 Diabetes Representing Different Disease Stages
    Koike, Masao
    Saito, Hitoki
    Kohno, Genta
    Takubo, Masahiro
    Watanabe, Kentaro
    Ishihara, Hisamitsu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
  • [42] Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA
    Khat, Dorrin Zarrin
    Husain, Mansoor
    CURRENT DIABETES REPORTS, 2018, 18 (07)
  • [43] Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice
    Fu, Edouard L.
    Clase, Catherine M.
    Janse, Roemer J.
    Lindholm, Bengt
    Dekker, Friedo W.
    Jardine, Meg J.
    Carrero, Juan-Jesus
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 352 : 172 - 179
  • [44] Stroke, acute myocardial infarction and mortality in type 2 diabetes: a nationwide comparative effectiveness study of GLP-1RA, SGLT2i and DPP-4i treatment
    Hastrup, S.
    Hedegaard, J.
    Andersen, G.
    Osler, M.
    Rungby, J.
    Johnsen, S.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S345 - S346
  • [45] GLP1RA Compared to SGLT2i Improves Depression Parameters in Veterans
    Jain, Arad
    Ubalde, Shannen Nicole
    Esper, Layal
    Powell, Joseph
    Meyer, Kristin
    Sen, Sabyasachi
    OBESITY, 2023, 31 : 87 - 88
  • [46] Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA
    Dorrin Zarrin Khat
    Mansoor Husain
    Current Diabetes Reports, 2018, 18
  • [47] Comparing Cardiovascular Benefits between GLP-1RA and SGLT2i as an Add-On to Metformin among US Adults with Type 2 Diabetes (T2D)
    Deremer, Christina E.
    Guo, Jingchuan
    Vouri, Scott M.
    Haller, Michael J.
    Donahoo, William T.
    Winterstein, Almut G.
    Shao, Hui
    DIABETES, 2021, 70
  • [48] Cardiovascular benefits of GLP-1RA and SGLT-2i in women with type 2 diabetes
    Mishriky, Basem M.
    Cummings, Doyle M.
    Powell, James R.
    PRIMARY CARE DIABETES, 2022, 16 (03) : 471 - 473
  • [49] Mitochondrial insights on antidiabetic therapies: Differential impacts of SGLT2i, GLP-1, and insulin
    Lin, Yu-Hsiang
    Chang, Kuo-Hsuan
    Lu, Yu-Jen
    PHARMACOLOGICAL RESEARCH, 2025, 212
  • [50] Protective Effect of GLP-1 Receptor Agonists (GLP-1 RA) and SGLT2 Inhibitors (SGLT2i) against Adverse Cardiovascular (CV) Events in HIV and Type 2 Diabetes Mellitus (T2DM) When Compared with Metformin Alone: A National Database Study
    Alaber, Omar A.
    Chandar, Apoorva K.
    Dahash, Basma A.
    Zuzek, Aleona C.
    Rajpal, Aman
    DIABETES, 2020, 69
12345